Hereditary hematologic malignancy (HM) syndromes are increasingly recognized as
causative of adult hematopoietic cancers, and the advent of next-generation sequencing has
accelerated the discovery of new syndromes based on dense clustering of these diseases in
particular families. Updated classifications schemes for myeloid malignancies will now
include recommendations for taking a family history on all patients diagnosed with
hematopoietic malignancies and for genetic counseling and testing of appropriate …